400 related articles for article (PubMed ID: 9869520)
1. Assessment of treatment for patients with primary ductal carcinoma in situ in the breast.
Fish EB; Chapman JA; Miller NA; Link MA; Fishell E; Wright B; McCready DR; Hiraki GY; Ross TM; Hanna WM; Lickley HL
Ann Surg Oncol; 1998 Dec; 5(8):724-32. PubMed ID: 9869520
[TBL] [Abstract][Full Text] [Related]
2. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.
Fisher B; Land S; Mamounas E; Dignam J; Fisher ER; Wolmark N
Semin Oncol; 2001 Aug; 28(4):400-18. PubMed ID: 11498833
[TBL] [Abstract][Full Text] [Related]
3. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
[TBL] [Abstract][Full Text] [Related]
4. Patterns of treatment for ductal carcinoma in situ of the breast in Louisiana, 1988-1999.
Wu X; Chen VW; Ruiz B; Andrews PA; Hsieh MC; Schmidt BA; Correa CN; Fontham ET
J La State Med Soc; 2003; 155(4):206-13. PubMed ID: 14506828
[TBL] [Abstract][Full Text] [Related]
5. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
Kerlikowske K; Molinaro A; Cha I; Ljung BM; Ernster VL; Stewart K; Chew K; Moore DH; Waldman F
J Natl Cancer Inst; 2003 Nov; 95(22):1692-702. PubMed ID: 14625260
[TBL] [Abstract][Full Text] [Related]
6. Twenty-year outcomes after breast-conserving surgery and definitive radiotherapy for mammographically detected ductal carcinoma in situ.
Wilkinson JB; Vicini FA; Shah C; Shaitelman S; Jawad MS; Ye H; Kestin LL; Goldstein NS; Martinez AA; Benitez P; Chen PY
Ann Surg Oncol; 2012 Nov; 19(12):3785-91. PubMed ID: 22644510
[TBL] [Abstract][Full Text] [Related]
7. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results.
Kestin LL; Goldstein NS; Martinez AA; Rebner M; Balasubramaniam M; Frazier RC; Register JT; Pettinga J; Vicini FA
Ann Surg; 2000 Feb; 231(2):235-45. PubMed ID: 10674616
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
9. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
10. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734
[TBL] [Abstract][Full Text] [Related]
11. Ductal carcinoma in situ: breast-conserving surgery without radiotherapy.
Hainsworth A; Fosh B; Raymond W; Eaton M; McLeay W
ANZ J Surg; 2015 Apr; 85(4):245-8. PubMed ID: 25039811
[TBL] [Abstract][Full Text] [Related]
12. Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.
Chuwa EW; Tan VH; Tan PH; Yong WS; Ho GH; Wong CY
ANZ J Surg; 2008; 78(1-2):42-8. PubMed ID: 18199204
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiotherapy versus observation following lumpectomy in ductal carcinoma in-situ: A meta-analysis of randomized controlled trials.
Garg PK; Jakhetiya A; Pandey R; Chishi N; Pandey D
Breast J; 2018 May; 24(3):233-239. PubMed ID: 28833776
[TBL] [Abstract][Full Text] [Related]
15. Modeling the effectiveness of initial management strategies for ductal carcinoma in situ.
Soeteman DI; Stout NK; Ozanne EM; Greenberg C; Hassett MJ; Schrag D; Punglia RS
J Natl Cancer Inst; 2013 Jun; 105(11):774-81. PubMed ID: 23644480
[TBL] [Abstract][Full Text] [Related]
16. Metastatic invasive breast cancer recurrence following curative-intent therapy for ductal carcinoma in situ.
Al Mushawah F; Rastelli A; Pluard T; Margenthaler JA
J Surg Res; 2012 Mar; 173(1):10-5. PubMed ID: 21696764
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.
Kestin LL; Goldstein NS; Lacerna MD; Balasubramaniam M; Martinez AA; Rebner M; Pettinga J; Frazier RC; Vicini FA
Cancer; 2000 Feb; 88(3):596-607. PubMed ID: 10649253
[TBL] [Abstract][Full Text] [Related]
19. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature.
Vicini FA; Recht A
J Clin Oncol; 2002 Jun; 20(11):2736-44. PubMed ID: 12039936
[TBL] [Abstract][Full Text] [Related]
20. Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.
Vidali C; Caffo O; Aristei C; Bertoni F; Bonetta A; Guenzi M; Iotti C; Leonardi MC; Mussari S; Neri S; Pietta N
Radiat Oncol; 2012 Oct; 7():177. PubMed ID: 23098066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]